TM Technologies, Inc.
29.2.2024 18:47:46 CET | ACCESS Newswire | Press release
Barcelona, Spain - Mobile World Congress 2024
BARCELONA, SPAIN / ACCESSWIRE / February 29, 2024 / TM Technologies has partnered with Switzerland's Quantum Resistant Cryptography, S.A. (QRC) to increase both the speed and security of wireless communications. QRC's cutting-edge encryption is nine orders of magnitude stronger than AES-256, providing unparalleled quantum resistance. The combination of TM Technologies' bandwidth-optimizing Cognitive Spectrum Optimization ("CSO") with QRC's best-of-class encryption is now capable of providing low-latency quantum-resistant communications at speeds that exceed current non-encrypted communications.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Logo for Header
The advent of quantum computing is widely understood to pose an imminent threat to the security of all conventionally encrypted information, including communications of passwords, transactions, and personal information.
The incorporation of QRC quantum-resistant encryption will initially be applied to three leading Transpositional Modulation use cases:
- Near Field Communications: Used commonly in point of sale from credit cards and mobile applications as well as in the hospitality and healthcare industries, the quantum-resistant QRC encryption combined with TM Technologies' CSO is estimated to exceed current NFC speeds by 13.5x.
- Satellite Communications: Whether geostationary, conventional LEO or LEO direct to device, TM + QRC offers a means to increase download speeds while greatly improving security.
- 5G / 6G: 3GPP-compatible and ORAN-compatible high-security use cases, such as in the enterprise, smart cities or law enforcement, can utilize this speed and security enhancement to stay ahead of emerging threats.
TM Technologies Director of Research and Development Dr. Scott Velasquez said, "Transpositional Modulation has existing security features that make it one of the most efficient and secure waveforms in existence, and our QRC partnership adds an important component of export-compliant quantum-resistant encryption that make sense for all customers interested in future-proofing their secure communications."
"TM Technologies' innovative solution has created dramatically faster contactless transactions," said Stiepan Kovac, founder and Group CEO of QRC. "Our advanced encryption adds the best security to this novel technology without negatively affecting the efficacy or speed. We are very proud of this novel collaboration."
About TM Technologies, Inc. www.tmtechnologies.com
TM Technologies is a privately held, independent technology research, development and intellectual property firm founded in 2013. With engineering and lab space in San Diego, California, and its administrative offices in Little Switzerland, North Carolina, TM provides software licenses and integrative engineering to customers in the fields of advanced wireless technologies, Near Field Communications and In-Band-Full-Duplex solutions.
About Quantum Resistant Cryptography, S.A. www.QRcrypto.ch
QRC provides forward-thinking encryption solutions that are energy-efficient, quantum-resistant, 5G/6G+-compatible and enable future-proof communications, public infrastructure, financial transactions, and private data protection. QRC's unique patented quantum-safe technology in 5G systems is the only solution recommended by the United Nations International Telecom Union (UN ITU-T).
Contact Information
Dan Hodges
CEO
info@tmtechnologies.com
(828) 330-4492
Related Images
SOURCE: TM Technologies
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom